[1]BioorganicandMedicinalChemistryLetters,2005,vol.15,p.3407-3411
[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2005/37198,2005,A2Locationinpatent:Page/Pagecolumn28
Title: (1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: further optimisation as highly potent and selective MSK-1-inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20050715